Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT05676450

Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas

Conditions: Lymphoma

Sex: All

Ages: 18 Years – N/A

Phase: NA

Enrollment: 517

Sponsor: M.D. Anderson Cancer Center

Location: United States

Summary

To test the feasibility of collecting cell-free DNA (cfDNA) samples from DLBCL patients before and after treatment. cfDNA is DNA traveling in your blood outside of a cell and is easily collected from blood samples drawn using the vein puncture method.

Eligibility Criteria

Inclusion Criteria:Male/female patients who are at least 18 years of age on the day of informed consent signing.Patients must have a histologically documented diffuse large B-cell lymphoma requiring therapy.Provision of written informed consent for the study.Pregnant women not includedCognitively impaired adults are not included.Exclusion Criteria:None

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05676450). StuddyBuddy aggregates publicly available trial information.